TCI Wealth Advisors’s Genomic Health, Inc. GHDX Stock Holding History

TCI Wealth Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-160	Closed	-$4K	–	1426
2016 Q1	$4K	Hold	160	–	–	﹤0.01%	807
2015 Q4	$6K	Hold	160	–	–	﹤0.01%	697
2015 Q3	$3K	Hold	160	–	–	﹤0.01%	758
2015 Q2	$4K	Buy	+160	New	+$4.51K	﹤0.01%	708
2015 Q1	–	Sell	-160	Closed	-$5K	–	989
2014 Q4	$5K	Hold	160	–	–	﹤0.01%	582
2014 Q3	$5K	Hold	160	–	–	﹤0.01%	584
2014 Q2	$4K	Hold	160	–	–	﹤0.01%	664
2014 Q1	$4K	Hold	160	–	–	﹤0.01%	622
2013 Q4	$5K	Hold	160	–	–	﹤0.01%	572
2013 Q3	$5K	Hold	160	–	–	﹤0.01%	504
2013 Q2	$5K	Buy	+160	New	+$5.25K	﹤0.01%	474

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCI Wealth Advisors's GHDX Position: Q2 2016 in Review

TCI Wealth Advisors sold out of Genomic Health, Inc. (GHDX) in Q2 2016, closing a stake of 160 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $6K in Q4 2015. 130 funds tracked by Wall St. Rank hold GHDX as of Q2 2016.

TCI Wealth Advisors reported no remaining Genomic Health, Inc. position as of Q2 2016 after selling out during the quarter.
TCI Wealth Advisors sold 160 Genomic Health, Inc. shares in Q2 2016, an estimated $4K.
TCI Wealth Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
TCI Wealth Advisors's Genomic Health, Inc. position peaked at $6K in Q4 2015.
130 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2016.

Based on TCI Wealth Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.